Not necessarily, FDA approval is a formality now. I'm sure there'll be a little bump in the SP but I wouldn't pin my hopes on it getting us back over 40c. I just want to see growth and if the SP lags that growth that's better for someone like myself who hasn't bought their whole allotment yet. FDA approval derisks us further, increased profit will come from it (for the quarter) but growth will come from being able to replicate the Access Bio deal quarter on quarter as well as others of similar size. I believe we'll be very attractive this year but as I said before it'll start with FDA approval. The rest of the year will only get better after that. If I had to guess I'd say before February, makes sense with when the application was put in and the extra stuffing about we had to do helping with the EUA.
AT1 Price at posting:
28.5¢ Sentiment: Buy Disclosure: Held
